Add BrightSurf on Google Email

World Diabetes Day (Nov.14): Bar-Ilan University researchers identify blood-based biomarkers that could help personalize treatment for autoimmune diabetes

Researchers at Bar-Ilan University have identified two blood biomarkers that can predict which mice will respond to a combination therapy for autoimmune diabetes, leading to long-term remission in one-third of treated mice. The study also showed that the treatment stimulated pancreatic regeneration, offering new insights into potential...

SourceBar-Ilan University·JournalMedComm·DateNov 9, 2026

New strategy identified for treating lupus

Researchers have identified a new strategy for treating lupus by targeting an imbalance in prolactin receptors, reducing inflammatory molecules and kidney damage while preserving healthy immune cells. This approach could potentially control disease activity and reduce the risk of organ damage.

SourceUniversity of California - Riverside·JournalExperimental & Molecular Medicine·TypeExperimental study·DateNov 2, 2026

Researchers identify common nutritional supplement as potential treatment for psoriasis

A study published in the Journal of Experimental Medicine found that pantethine reduces skin inflammation in mice and shows potential benefits in humans when used in combination with other treatments. Pantethine supplementation also alleviates psoriasis symptoms in patients, particularly those with elevated blood cholesterol levels.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·TypeExperimental study·DateOct 27, 2026

How dismissed symptoms can push patients to breaking point

A new study reveals concerns about misdiagnosis and stigma in autoimmune diseases with functional neurological disorder (FND), highlighting the need for better communication and holistic care. Patients and clinicians often see things differently, and poor explanations can lead to feelings of guilt, shame, and suicidal thoughts.

SourceUniversity of East Anglia·JournalRheumatology International·TypeSurvey·DateOct 26, 2026

Curbing the neutrophil surge: New treatment offers hope for autoimmune diseases

Researchers from the University of Osaka have uncovered the first steps in the development of ANCA-associated glomerulonephritis, a kidney disease triggered by ANCAs. They found that injured kidney cells send signals attracting immune cells, including neutrophils, which drive inflammation in the early stages.

SourceImmunology Frontier Research Center (IFReC) - The University of Osaka·JournalJournal of Experimental Medicine·TypeExperimental study·DateOct 19, 2026

Continuous glucose monitors help type 2 diabetes patients spend five more hours a day in healthy blood sugar range

A large-scale clinical trial found that adults using continuous glucose monitors (CGMs) spent approximately 5 additional hours each day within their target blood sugar range compared to those receiving routine care. Nearly twice as many CGM users achieved an A1c level below 7%, a common treatment goal for people with diabetes.

SourceUniversity of Colorado Anschutz·JournalNew England Journal of Medicine·DateOct 14, 2026

Females with autoimmune diseases ‘less likely to be believed’ than males and face longer diagnostic delays

A study of 6,607 patients with autoimmune diseases found females were more likely to be misdiagnosed as psychiatric or psychosomatic conditions, with longer diagnostic delays. Females reported higher rates of psychiatric and psychosomatic misdiagnoses, while males were more likely to be diagnosed with other physical diseases.

SourceUniversity of Cambridge·JournalEClinicalMedicine·TypeSurvey·DateOct 12, 2026

Recreating key features of the antibody factory in a dish

Scientists at the University of Osaka have developed a method to recreate human B cells with germinal center features using three immune signals, which closely match those found in human tonsils. This breakthrough could help improve vaccine-induced antibody responses and identify targets for autoimmune disease.

SourceImmunology Frontier Research Center (IFReC) - The University of Osaka·JournalScience Immunology·TypeExperimental study·DateSep 29, 2026

Receptor-free signal transduction: Discovery of new method for inflammatory cell communication opens door for therapeutic opportunities in treating autoimmune diseases

Researchers at Boston Children's Hospital discovered a receptor-free means of signal transduction, identifying a potentially more effective therapeutic target for treating autoimmune diseases. This new method suggests alternative pathways for cell-to-cell communication, which may lead to the development of new therapeutic treatments.

SourceBoston Children's Hospital·JournalNature·DateSep 23, 2026

Scientists uncover shared biology behind profound fatigue in five major illnesses

A new study reveals striking biological similarities between five major illnesses, including long Covid and PTSD, suggesting common underlying mechanisms. Chronic fatigue syndrome, rheumatoid arthritis, and multiple sclerosis may be driven by shared regulatory networks in immune and metabolic systems.

SourceUniversity of East Anglia·JournalJournal of Translational Medicine·TypeComputational simulation/modeling·DateSep 2, 2026

Immune drug anifrolumab linked to lower risk of infection and hospitalization for skin lupus

The study found that patients taking anifrolumab had lower rates of infections requiring hospitalization compared to those on conventional immunosuppressants. Anifrolumab also reduced the need for systemic antibiotics and increased the likelihood of viral infections, offering distinct benefits over conventional treatments.

SourceJohns Hopkins Medicine·JournalJournal of the European Academy of Dermatology and Venereology·DateSep 2, 2026

ISB researchers identify immune cells that drive harmful autoantibody responses after COVID-19

Researchers have identified a subset of B cells known as atypical memory cells as the primary precursors of autoantibody-producing cells during SARS-CoV-2 infection. These cells adopt a markedly different biological program, leading to increased autoantibody production. The study provides new insight into how viral infections can trigg...

SourceInstitute for Systems Biology·JournalImmunity·DateAug 28, 2026

New approach opens rare immune cells to genetic risk research

Researchers developed a new method to study long-distance DNA regulation in rare immune cells, uncovering previously hidden connections relevant to autoimmune diseases. The approach prioritized over 100 candidate genes linked to Crohn's disease risk, including CLN3, which was not typically associated with the condition.

SourceCincinnati Children's Hospital Medical Center·JournalNature Genetics·TypeData/statistical analysis·DateAug 4, 2026

$5 million gift establishes Colton Center for Autoimmunity at Mount Sinai to advance precision medicine for autoimmune diseases

The new center at Mount Sinai will join the Colton Consortium for Autoimmunity, expanding research on earlier detection, precision treatment, and disease prevention for people with autoimmune diseases. The Center aims to develop more precise, effective treatments across multiple diseases by understanding shared immune pathways.

New data highlight off-the-shelf iPSC-derived CAR T-cell therapy for treatment-resistant systemic sclerosis

Early signs of clinical improvement have been observed in patients with treatment-resistant systemic sclerosis treated with investigational stem cell-derived CAR T-cell therapy, known as FT819. The therapy has demonstrated a reassuring safety profile and has the potential to expand access to patients who might otherwise face barriers t...

Physical exercise could help modulate the immune response in type 1 diabetes

A review published in Diabetes Care suggests that physical exercise could play a role in promoting immune regulation, preserving beta-cell function, and reducing inflammation in type 1 diabetes. The evidence highlights the potential benefits of exercise on immune profiles displaying anti-inflammatory characteristics.

SourceGermans Trias i Pujol Research Institute·JournalDiabetes Care·TypeLiterature review·DateJun 23, 2026